An official website of the United States government
These tables are also available in a printable version (PDF, 273 KB).
Please refer to your standard setter(s) for specific reporting requirements before using the Casefinding List
Comprehensive ICD-10 Casefinding "Must Collect"
Code List for Reportable Tumors (Effective Date: 1/1/2012)
| ICD-10 Code^ | Explanation of Code |
|---|---|
| B21._ | Human Immunodeficiency virus [HIV] disease with malignant neoplasms |
| C00._ – C97._ | Malignant neoplasms Note: Pilocytic/juvenile astrocytoma M-9421 moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. However, SEER registries will CONTINUE to report these cases and code behavior as /3 (malignant). |
| D00._ - D09._ | In-situ neoplasms Note: Carcinoma in situ of the cervix (CIN III-8077/2) and Prostatic Intraepithelial Carcinoma (PIN III-8148/2) are not reportable. |
| D18.0 | Hemangioma, any site Note: Includes Hemangiomas of Brain, Other parts of nervous system and endocrine glands, which are reportable. |
| D18.1 | Lymphangioma, any site Note: Includes Lymphangiomas of Brain, Other parts of nervous system and endocrine glands, which are reportable. |
| D32._ | Benign neoplasm of meninges (cerebral, spinal and unspecified) |
| D33._ | Benign neoplasm of brain and other parts of central nervous system |
| D35.2 | Benign neoplasm of pituitary gland |
| D35.3 | Benign neoplasm of craniopharyngeal duct |
| D35.4 | Benign neoplasm of pineal gland |
| D42._ | Neoplasm of uncertain or unknown behavior of meninges |
| D43._ | Neoplasm of uncertain or unknown behavior of brain and central nervous system |
| D44.3 – D44.5 | Neoplasm of uncertain or unknown behavior of pituitary gland, craniopharyngeal duct and pineal gland |
| D45 | Polycythemia vera (9950/3) |
| D46._ | Myelodysplastic syndromes (9980, 9982, 9983, 9985, 9986, 9989, 9991, 9992) |
| D47.1 | Chronic myeloproliferative disease (9960/3, 9961/3, 9963/3) |
| D47.3 | Esssential (hemorrhagic) thrombocythemia (9962/3) |
| D47.7 | Other specified neoplasms of uncertain/unknown behavior of lymphoid, hematopoietic (9965/3, 9966/3, 9967/3, 9971/3, 9975/3, 9987/3) |
| D47.9 | Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified (9960/3, 9961/3, 9970/1, 9931/3) |
| D48.9 | Neoplasm of uncertain or unknown behavior, unspecified Note: Review code for uncertain behavior brain, CNS tumors and reportable benign endocrine glands |
| D76._ | Certain diseases involving lymphoreticular tissue and reticulohistiocytic system |
NOTE: Cases with these codes should be screened as registry time allows. These are neoplasm-related secondary conditions for which there should also be a primary diagnosis of a reportable neoplasm. Experience in the SEER registries has shown that using the supplementary list increases casefinding for benign brain and CNS, hematopoietic, and other reportable neoplasms.
(This list is to be used to help identify cases that MAY be reportable to the cancer registry. This is not a list of Reportable Neoplasms or reportable terms)
Supplementary List: ICD-10 Code List to Screen for Cancer Cases Not Identified by Other Codes (Effective Date: 1/1/2012)
| ICD-10 Code^ | Explanation of Code |
|---|---|
| B20._, B22 - B24 | Human immunodeficiency virus [HIV] disease with other diseases Note: Excludes HIV with malignancy (B21), see reportable list |
| B99 | Other infectious diseases (Human papillomavirus, Retrovirus-HTLV types I, II, 2 |
| D10._ - D31._, D34, D35.0, D35.1, D35.5 - D35.9, D36._ |
Benign neoplasms (see “must collect” list for reportable benign neoplasms) Note: Screen for incorrectly coded malignancies or reportable by agreement tumors Note: Borderline cystadenomas M-8442, 8451, 8462, 8472, 8473, of the ovaries moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. SEER registries are not required to collect these cases for diagnoses made 1/1/2001 and after. However, cases diagnosed prior to 1/1/2001 should still be abstracted and reported to SEER. |
| D37._ – D41._ | Neoplasms of uncertain or unknown behavior (see “must collect” list for Reportable Neoplasms of uncertain or unknown behavior) Note: Screen for incorrectly coded malignancies or reportable by agreement tumors |
D44.0 - D44.2, D44.6 - D44.9 |
Neoplasm of uncertain or unknown behavior of other endocrine glands (see “must collect” list for D44.3-D44.5) Note: Screen for incorrectly coded malignancies or reportable by agreement tumors |
| D47.0 | Histiocytic and mast cell tumors of uncertain behavior |
| D47.2 | Monoclonal gammopathy Note: Screen for incorrectly coded Waldenstrom’s macroglobulinemia |
| D48._ | Neoplasms of uncertain or unknown behavior Note: Screen for incorrectly coded malignancies or reportable by agreement tumors |
| D60._ | Acquired pure red cell aplasia [erythroblastopenia] Note: Screen for anemia disorder related to neoplasm |
| D61.1 – D61.9 | Other aplastic anemias Note: Review for miscodes |
| D63.0 | Anemia in neoplastic disease |
| D64._ | Other anemias Note: Screen for anemia disorder related to neoplasm |
| D69.4 – D69.9 | Other thrombocytopenia Note: Screen for incorrectly coded thrombocythemia |
| D70 | Agranulocytosis Note: Screen for blood disorders due to neoplasm |
| D72.1 | Eosinophilia Note: This is the code for eosinophilia (9964/3). Not every case of eosinophilia is associated with a malignancy. Diagnosis must be “Hypereosonophilic syndrome” to be reportable. |
| D75.8 | Other specified diseases of blood and blood forming organs Note: This is the code for myelofibrosis (NOS) (9961/3). Not every case of myelofibrosis is associated with a malignancy. Review terms included in ICD-O-3 to determine if case is reportable. |
| D80.3 – D80.5 | Selective deficiency of immunoglobulin Note: Associated with lymphoproliferative disorders |
| D81.0 – D81.2 | Severe combined immunodeficiency [SCID] Note: Associated with lymphoproliferative disorders |
| D84.9 | Immunodeficiency, unspecified Note: Associated with lymphoproliferative disorders |
| D89._ | Other disorders involving the immune mechanism, not elsewhere classified Note: Review for miscodes |
| E13._ | Other specified diabetes mellitus Note: Includes diabetes with underlying malignancy |
| E31.9 | Polyglandular dysfunction, unspecified Note: This is the code for “multiple endocrine neoplasia (MEN) type IIA and IIB (rare familial cancer syndrome) “ |
| E88.0 | Disorders of plasma-protein metabolism, not elsewhere classified Note: Screen for incorrectly coded Waldenstrom’s macroglobulinemia |
| E88.8 | Other specified metabolic disorders Note: Includes Tumor lysis syndrome following antineoplastic drug |
| G31.8 | Other specified degenerative diseases of nervous system Note: Includes myelopathy in neoplastic disease |
| G52.8 |
Disorders of other specified cranial nerves Note: Includes myelopathy in neoplastic disease |
| G54.8 | Other nerve root and plexus disorders Note: Includes nerve root and plexus compressions in neoplastic disease |
| G62.8 | Other specified polyneuropathies Note: Includes polyneuropathy disorders in neoplastic disease |
| G70.8 | Other specified myoneural disorders Note: Includes Eaton-Lambert syndrome in neoplastic disease |
| G90.8 | Other disorders of autonomic nervous system Note: Includes myelopathy in neoplastic diseases |
| G91.8 | Other hydrocephalus Note: Includes hydrocephalus in neoplastic diseases |
| G96.8 | Other specified disorders of central nervous system Note: Includes neuropathy in neoplastic disease |
| J84.8 | Other specified interstitial pulmonary diseases Note: Includes Adult pulmonary Langerhans cell histiocytosis |
| J90 | Pleural effusion, not elsewhere classified Note: Includes malignant pleural effusion |
| J93.1 | Other spontaneous pneumothorax Note: Includes secondary spontaneous pneumothorax due to neoplasm |
| M12.8 | Other specific arthropathies, not elsewhere classified Note: Includes arthropathy in neoplastic disease |
| M62.8 | Other specified disorders of muscle Note: Includes disorders of muscles (due to) neoplasm |
| M84.4 | Pathologic fracture, not elsewhere classified Note: Includes fracture due to neoplasm |
| M89.8 | Other specified disorders of bone Note: Includes osteitis deformans in neoplastic disease |
| O01._ | Hydatidiform mole Note: This is a benign tumor that can become malignant. If malignant, it should be reported as Choriocarcinoma (9100/3) and will have a malignancy code in the C00- C97 range |
| O99.8 | Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium Note: Includes: malignant neoplasm complicating pregnancy, childbirth and the pueperium |
| Q85.0 | Neurofibromatosis (nonmalignant) (9540/1) Note: Neurofibromatosis by itself is not reportable, but it can lead to a reportable condition |
| Q90._ | Down’s syndrome Note: Screen for myeloid leukemia associated with Down’s Syndrome (9898/3) |
| R18 | Ascites Note: Includes malignant ascites |
| R52.9 | Pain, unspecified Note: Includes neoplasm related pain (acute, chronic); Cancer associated pain; Pain due to malignancy (primary/secondary); Tumor associated pain |
| R53 | Malaise and fatigue Note: Includes neoplasm related fatigue |
| R59._ | Enlarged lymph nodes Note: Screen for large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease (9738/3) |
| R82.8 | Abnormal findings on cytological and histological examination of urine |
| R83.6, R83.7 | Abnormal findings on cytological and histological examination of cerebrospinal fluid |
| R84.6, R84.7 | Abnormal findings on cytological and histological examination of respiratory organs and thorax |
| R85.6, R85.7 | Abnormal findings on cytological and histological examination of digestive organs and abdominal cavity |
| R86.6, R86.7 | Abnormal findings on cytological and histological examination of male genital organs |
| R87.6, R87.7 | Abnormal findings on cytological and histological examination of female genital organs |
| R89.6, R89.7 | Abnormal findings on cytological and histological examination of other organs systems and tissues |
| R91 | Abnormal findings on diagnostic imaging of lung |
| R92 | Abnormal findings on diagnostic imaging of breast |
| Y42.1 | Other and unspecified hormone antagonists (poisoning) |
| Y42.6 | Adverse reaction to antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified |
| Y43.1 - Y43.4 | Adverse effects in therapeutic use, antineoplastic products or drugs |
| Y43.9 | Adverse effects in therapeutic use, primarily systemic agent, unspecified Note: Includes poisoning by primarily systemic and hematological agents |
| Y44.9 | Other and unspecified agents affecting blood constituents Note: Includes bloodstream infection due to central venous catheter |
| Y63.2 | Failure in dosage, overdose of radiation given during therapy Note: Includes adverse reaction to radiation (see also Y84.2) |
| Y81.2 | General and plastic surgery devices associated with adverse incidents-prosthetic and other implants, materials, and accessory devices Note: Includes complications due to breast prosthesis |
| Y83.0 | Surgical operation with transplant of whole organ Note: Includes complications of transplant |
| Y84.2 | Abnormal reaction, radiological procedure and radiotherapy Note: Includes adverse reaction to radiation |
| Y84.9 | Other medical procedures (abnormal reaction) Note: Includes infection due to central venous catheter (see code Y44.9 for bloodstream infection) |
The following codes are associated with the paraneoplastic syndrome. Paraneoplastic syndrome by itself is not cancer. It’s a disease or symptom that is the consequence of cancer but is not due to the local presence of cancer cells. A paraneoplastic syndrome may be the first sign of cancer. These codes have been removed from the Supplemental Listand are now in their own list.
| ICD-10 Code^ | Explanation of Code |
|---|---|
| E22.2 | Syndrome of inappropriate secretion of antidiuretic hormone |
| E34.0 | Carcinoid syndrome |
| E34.1 | Other hypersecretion of intestinal hormones |
| E34.8 | Other specified endocrine disorders |
| E83.5 | Disorders of calcium metabolism |
| G04.8 | Other encephalitis, myelitis, and encephalomyelitis |
| H55 | Nystagmus and other irregular eye movements |
| L10.8 | Other pemphigus |
| L30.4 | Erythrema intertrigo |
| L53.8 | Other specified erythematous conditions |
| L83 | Acanthosis nigricans |
| L88 | Pyoderma gangrenosum |
| L98.2 | Febrile neutrophilic dermatosis [Sweet] |
| M33.2 | Polymyositis |
| M33.9 | Dermatopolymyositis, unspecified |
^ World Health Organization. International Statistical Classification of Diseases and Related Health problems, Tenth Revision. Geneva: World Health Organization. 2007
